Trial Outcomes & Findings for Clinical Evaluation of Two Approved Contact Lenses (NCT NCT02759692)
NCT ID: NCT02759692
Last Updated: 2017-08-18
Results Overview
Overall comfort was assessed using the Contact Lens User Experience™ (CLUE) questionnaire. CLUE is a validated patient-reported outcomes (PRO) questionnaire to assess patient-experience attributes of soft contact lenses (comfort, vision, handling, and packaging) in a contact-lens wearing population in the US, ages 18-65. Derived CLUE scores using Item Response Theory (IRT) follow a normal distribution with a population average score of 60 (SD 20), where higher scores indicate a more favorable/positive response with a range of 0-120. Please note this was a 2 treatment by 3 period study design. Therefore, some subjects were randomized to receive one of the study lenses twice, hence the number of observations were summarized per lens type. For the senofilcon A lens 132+136+132=400 (Observations- 1 per subject per period) from period 1, 2 and 3 respectively. For the stenfilcon A lens 136+132+136=404 (observations) from period 1, 2 and 3 respectively.
COMPLETED
NA
283 participants
7-Day Follow-up
2017-08-18
Participant Flow
A total of 283 subjects were enrolled into this study. Of the enrolled subjects all were dispensed at least one study lens. Of the dispensed subjects 276 subjects completed the study and 7 subjects were discontinued.
Participant milestones
| Measure |
Senofilcon A/ Stenfilcon A/ Senofilcon A
Subjects randomized to this sequence received the senofilcon A lens during the first period, the stenfilcon A lens during the second period and the senofilcon A lens during the third period.
|
Stenfilcon A/ Senofilcon A/ Stenfilcon A
subjects randomized to this sequence received the stenfilcon A lens during the first period, the senofilcon A lens during the second period and the stenfilcon A lens during the third period.
|
|---|---|---|
|
Period 1
STARTED
|
141
|
142
|
|
Period 1
COMPLETED
|
138
|
140
|
|
Period 1
NOT COMPLETED
|
3
|
2
|
|
Period 2
STARTED
|
138
|
140
|
|
Period 2
COMPLETED
|
137
|
139
|
|
Period 2
NOT COMPLETED
|
1
|
1
|
|
Period 3
STARTED
|
137
|
139
|
|
Period 3
COMPLETED
|
137
|
139
|
|
Period 3
NOT COMPLETED
|
0
|
0
|
Reasons for withdrawal
| Measure |
Senofilcon A/ Stenfilcon A/ Senofilcon A
Subjects randomized to this sequence received the senofilcon A lens during the first period, the stenfilcon A lens during the second period and the senofilcon A lens during the third period.
|
Stenfilcon A/ Senofilcon A/ Stenfilcon A
subjects randomized to this sequence received the stenfilcon A lens during the first period, the senofilcon A lens during the second period and the stenfilcon A lens during the third period.
|
|---|---|---|
|
Period 1
Test article no longer available
|
1
|
1
|
|
Period 1
No longer meets eligibility criteria.
|
1
|
0
|
|
Period 1
Miss-Randomized
|
1
|
1
|
|
Period 2
Lost to Follow-up
|
1
|
0
|
|
Period 2
Test article no longer available
|
0
|
1
|
Baseline Characteristics
Clinical Evaluation of Two Approved Contact Lenses
Baseline characteristics by cohort
| Measure |
Dispensed Subjects
n=276 Participants
All subjects that were dispensed at least one study lens.
|
|---|---|
|
Age, Continuous
|
28.0 Years
STANDARD_DEVIATION 5.75 • n=99 Participants
|
|
Sex: Female, Male
Female
|
184 Participants
n=99 Participants
|
|
Sex: Female, Male
Male
|
92 Participants
n=99 Participants
|
|
Race/Ethnicity, Customized
American Indian or Alaska Native
|
1 Participants
n=99 Participants
|
|
Race/Ethnicity, Customized
Asian
|
8 Participants
n=99 Participants
|
|
Race/Ethnicity, Customized
Black or African American
|
30 Participants
n=99 Participants
|
|
Race/Ethnicity, Customized
White
|
237 Participants
n=99 Participants
|
|
Region of Enrollment
United States
|
276 Participants
n=99 Participants
|
PRIMARY outcome
Timeframe: 7-Day Follow-upPopulation: Subjects that completed all study visits without a major protocol deviation.
Overall comfort was assessed using the Contact Lens User Experience™ (CLUE) questionnaire. CLUE is a validated patient-reported outcomes (PRO) questionnaire to assess patient-experience attributes of soft contact lenses (comfort, vision, handling, and packaging) in a contact-lens wearing population in the US, ages 18-65. Derived CLUE scores using Item Response Theory (IRT) follow a normal distribution with a population average score of 60 (SD 20), where higher scores indicate a more favorable/positive response with a range of 0-120. Please note this was a 2 treatment by 3 period study design. Therefore, some subjects were randomized to receive one of the study lenses twice, hence the number of observations were summarized per lens type. For the senofilcon A lens 132+136+132=400 (Observations- 1 per subject per period) from period 1, 2 and 3 respectively. For the stenfilcon A lens 136+132+136=404 (observations) from period 1, 2 and 3 respectively.
Outcome measures
| Measure |
Senofilcon A
n=400 Observations
Subjects that received the senofilcon A lens during any of the three study periods.
|
Stenfilcon A
n=404 Observations
Subjects that received the stenfilcon A lens during any three of the study periods.
|
|---|---|---|
|
Overall Comfort
|
72.5 Units on a Scale
Standard Deviation 27.9
|
63.8 Units on a Scale
Standard Deviation 30.1
|
PRIMARY outcome
Timeframe: 7-Day Follow-upPopulation: Subjects that completed all study visits without a major protocol deviation.
Overall quality of vision was assessed using the Contact Lens User Experience™ (CLUE) questionnaire. CLUE is a validated patient-reported outcomes (PRO) questionnaire to assess patient-experience attributes of soft contact lenses (comfort, vision, handling, and packaging) in a contact-lens wearing population in the US, ages 18-65. Derived CLUE scores using Item Response Theory (IRT) follow a normal distribution with a population average score of 60 (SD 20), where higher scores indicate a more favorable/positive response with a range of 0-120. Please note this was a 2 treatment by 3 period study design. Therefore, some subjects were randomized to receive one of the study lenses twice, hence the number of observations were summarized per lens type. For the senofilcon A lens 132+136+132=400 (Observations- 1 per subject per period) from period 1, 2 and 3 respectively. For the stenfilcon A lens 136+132+136=404 (observations) from period 1, 2 and 3 respectively.
Outcome measures
| Measure |
Senofilcon A
n=400 Observations
Subjects that received the senofilcon A lens during any of the three study periods.
|
Stenfilcon A
n=404 Observations
Subjects that received the stenfilcon A lens during any three of the study periods.
|
|---|---|---|
|
Overall Quality of Vision
|
67.5 Units on a Scale
Standard Deviation 20.6
|
62.1 Units on a Scale
Standard Deviation 22.3
|
SECONDARY outcome
Timeframe: 7-Day Follow-upPopulation: Subjects that completed all study visits without a major protocol deviation.
Individual patient reported outcomes questions were used to assess patient-experience attributes of soft contact lenses (e.g. comfort and vision). Items were assessed at the 7-Day follow-up using a 5-point scale of either (1) Strongly Disagree, Disagree, Neither Agree nor Disagree, Agree, Strongly Agree or (2) Poor, Fair, Good, Very Well, Excellent. Subject's responses for each item were dichotomoized into top-two-box (T2B) response where T2B=1 if a subject responded positively to the question which is dependent on the response set) and T2B=0 otherwise. The percentage of T2B for each item and lens was reported. The following items were asked: (\[\] indicate the question was abbreviated due to space)1."These Lenses Were Very Comfortable At The End Of The Day" 2."The Comfort of these lenses decreased throughout the day" 3. The lenses were very comfortable from the time I got up to the time I went to bed" 4. "Overall Comfort" 5. "Comfort throughout the Day"
Outcome measures
| Measure |
Senofilcon A
n=400 Observations
Subjects that received the senofilcon A lens during any of the three study periods.
|
Stenfilcon A
n=404 Observations
Subjects that received the stenfilcon A lens during any three of the study periods.
|
|---|---|---|
|
Individual Patient Reported Outcomes (Items 1-5)
[Lenses were very comfortable at end of day]
|
75.1 Percentage of Responses
|
65.1 Percentage of Responses
|
|
Individual Patient Reported Outcomes (Items 1-5)
[Comfort of lenses decreased during day]
|
68.5 Percentage of Responses
|
58.1 Percentage of Responses
|
|
Individual Patient Reported Outcomes (Items 1-5)
[Comfortable lenses when i got up to bed time]
|
75 Percentage of Responses
|
61.1 Percentage of Responses
|
|
Individual Patient Reported Outcomes (Items 1-5)
Overall Comfort
|
79.5 Percentage of Responses
|
67.5 Percentage of Responses
|
|
Individual Patient Reported Outcomes (Items 1-5)
Comfort Throughout the Day
|
72.3 Percentage of Responses
|
58.2 Percentage of Responses
|
SECONDARY outcome
Timeframe: 7-Day Follow-upPopulation: Subjects that completed all study visits without a major protocol deviation.
Individual patient reported outcomes questions were used to assess patient-experience attributes of soft contact lenses (e.g. comfort and vision). Items were assessed at the 7-Day follow-up using a 5-point scale of either (1) Strongly Disagree, Disagree, Neither Agree nor Disagree, Agree, Strongly Agree or (2) Poor, Fair, Good, Very Well, Excellent. Subject's responses for each item were dichotomoized into top-two-box (T2B) response where T2B=1 if a subject responded positively to the question which is dependent on the response set) and T2B=0 otherwise. The percentage of T2B for each item and lens was reported. The following items were asked: (\[\] indicate the question was abbreviated due to space)6. "Comfort at the end of the day" 7. They remained comfortable from the moment I put them in until the moment I took them out" 8."Comfort from activity to activity" 9. Comfort across different environments" 10."Comfort while working on a computer"
Outcome measures
| Measure |
Senofilcon A
n=400 Observations
Subjects that received the senofilcon A lens during any of the three study periods.
|
Stenfilcon A
n=404 Observations
Subjects that received the stenfilcon A lens during any three of the study periods.
|
|---|---|---|
|
Individual Patient Reported Outcomes (Items 6-10)
[Remained Comfortable from Insertion to Removal]
|
79.3 Percentage of Responses
|
69.8 Percentage of Responses
|
|
Individual Patient Reported Outcomes (Items 6-10)
Comfort Activity to Activity
|
81.6 Percentage of Responses
|
69.8 Percentage of Responses
|
|
Individual Patient Reported Outcomes (Items 6-10)
Comfort Across Different Environments
|
78.3 Percentage of Responses
|
66.9 Percentage of Responses
|
|
Individual Patient Reported Outcomes (Items 6-10)
[Comfort Working on a computer]
|
79.3 Percentage of Responses
|
70.3 Percentage of Responses
|
|
Individual Patient Reported Outcomes (Items 6-10)
[Satisfied with Distance Visions at Insertion]
|
91.3 Percentage of Responses
|
90.2 Percentage of Responses
|
SECONDARY outcome
Timeframe: 7-Day Follow-upPopulation: Subjects that completed all study visits without a major protocol deviation.
Individual patient reported outcomes questions were used to assess patient-experience attributes of soft contact lenses (e.g. comfort and vision). Items were assessed at the 7-Day follow-up using a 5-point scale of either (1) Strongly Disagree, Disagree, Neither Agree nor Disagree, Agree, Strongly Agree or (2) Poor, Fair, Good, Very Well, Excellent. Subject's responses for each item were dichotomoized into top-two-box (T2B) response where T2B=1 if a subject responded positively to the question which is dependent on the response set) and T2B=0 otherwise. The percentage of T2B for each item and lens was reported. The following items were asked: (\[\] indicate the question was abbreviated due to space). 11."I was very satisfied with my distance vision when i first put these lenses in my eyes. 12."I was very satisfied by the clarity of my vision at the end of the day" 13."I was satisfied with the quality of my vision at night" 14."With these lenses, I felt very confident to drive at night"
Outcome measures
| Measure |
Senofilcon A
n=400 Observations
Subjects that received the senofilcon A lens during any of the three study periods.
|
Stenfilcon A
n=404 Observations
Subjects that received the stenfilcon A lens during any three of the study periods.
|
|---|---|---|
|
Individual Patient Reported Outcomes (Items 11-14)
[Satisfied with Distance Vision]
|
91.3 Percentage of Responses
|
90.2 Percentage of Responses
|
|
Individual Patient Reported Outcomes (Items 11-14)
[Satisfied with Clarity of Vision at end of day]
|
85.8 Percentage of Responses
|
77.3 Percentage of Responses
|
|
Individual Patient Reported Outcomes (Items 11-14)
[Satisfied with my Quality of Vision at Night]
|
89.9 Percentage of Responses
|
84.2 Percentage of Responses
|
|
Individual Patient Reported Outcomes (Items 11-14)
[Confidence to Drive at Night with these lenses]
|
91.3 Percentage of Responses
|
86.9 Percentage of Responses
|
SECONDARY outcome
Timeframe: 7-Day Follow-upPopulation: Subjects that completed all study visits without a major protocol deviation.
Individual patient reported outcomes questions were used to assess patient-experience attributes of soft contact lenses (e.g. comfort and vision). Items were assessed at the 7-Day follow-up using a 5-point scale of either (1) Strongly Disagree, Disagree, Neither Agree nor Disagree, Agree, Strongly Agree or (2) Poor, Fair, Good, Very Well, Excellent. Subject's responses for each item were dichotomoized into top-two-box (T2B) response where T2B=1 if a subject responded positively to the question which is dependent on the response set) and T2B=0 otherwise. The percentage of T2B for each item and lens was reported. The following items were asked: (\[\] indicate the question was abbreviated due to space). 15."Clarity of vision during daily activities" 16."Clarity of vision in dim or low lighting conditions" 17. "Clarity of visions when driving at night".
Outcome measures
| Measure |
Senofilcon A
n=400 Observations
Subjects that received the senofilcon A lens during any of the three study periods.
|
Stenfilcon A
n=404 Observations
Subjects that received the stenfilcon A lens during any three of the study periods.
|
|---|---|---|
|
Individual Patient Reported Outcomes (Items 15-17)
Clarity of Vision During Daily Activities
|
85.6 Percentage of Responses
|
74.5 Percentage of Responses
|
|
Individual Patient Reported Outcomes (Items 15-17)
[Clarity of Vision in Dim or Low Lighting]
|
83.3 Percentage of Responses
|
73.8 Percentage of Responses
|
|
Individual Patient Reported Outcomes (Items 15-17)
Clarity of Vision When Driving at Night
|
81.5 Percentage of Responses
|
70.8 Percentage of Responses
|
Adverse Events
Senofilcon A
Stenfilcon A
Serious adverse events
| Measure |
Senofilcon A
n=141 participants at risk
Subjects that received the senofilcon A lens during any of the three study periods.
|
Stenfilcon A
n=142 participants at risk
Subjects that received the stenfilcon A lens during any three of the study periods.
|
|---|---|---|
|
General disorders
Hospitalization
|
0.00%
0/141 • Throughout the entire duration of the study. Approximately 30 days per subject.
|
0.70%
1/142 • Number of events 1 • Throughout the entire duration of the study. Approximately 30 days per subject.
|
Other adverse events
Adverse event data not reported
Additional Information
Brian Pall, OD, MS, FAAO
Johnson & Johnson Vision Care Inc.
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place
Restriction type: GT60